6-Diazo-5-oxo-L-norleucine-cancer research-TOKU-E
FD49029 | 157-03-9 | 6-Diazo-5-oxo-L-norleucine
Chemical structure of 6-diazo-5-oxo-l-norleucine (DON) and the prodrug... | Download Scientific Diagram
6-Diazo-5-oxo-L-norleucine - Wikipedia
6-Diazo-5-oxo-L-norleucine - Wikipedia
Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis | Journal of Virology
File:6-diazo-5-oxo-L-norleucine.png - Wikimedia Commons
6-Diazo-5-oxo-L-norleucine - Wikipedia
157-03-9 | 6-Diazo-5-oxo-L-norleucine | = 99% (Assay by titration) - Chem-Impex International
N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo- 5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated Neurocognitive Disorders | Journal of Medicinal Chemistry
6-Diazo-5-oxo-L-norleucine | C6H9N3O3 | ChemSpider
Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma | Journal of Medicinal Chemistry
6-Diazo-5-oxo-L-norleucine for Sale from Quality Suppliers - ECHEMI
6-Diazo-5-oxo-L-Norleucine | VWR
WO2016112386A1 - Methods for bioanalysis of 6-diazo-5-oxo-l-norleucine (don) and other glutamine antagonists - Google Patents
6-Diazo-5-oxo-L-norleucine ≥98.0% (UV) | Sigma-Aldrich
Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs | Journal of Medicinal Chemistry
The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells
6-Diazo-5-oxo-L-norleucine (CAS 157-03-9) | Glentham Life Sciences
The glutamine antagonist 6-diazo-5-oxo-L-norleucine is the most... | Download Scientific Diagram
Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs | Journal of Medicinal Chemistry
a U251 were treated with l-asparaginase and/or... | Download Scientific Diagram
6 Diazo 5 Oxonorleucine - an overview | ScienceDirect Topics
6-diazo-5-oxo-L-norleucine | C6H9N3O3 - PubChem
Feasibility and antitumor efficacy in vivo, of simultaneously targeting glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6‑ diazo‑5‑oxo‑L‑norleucine and orlistat in colon cancer
6-Diazo-5-oxo-L-norleucine ≥98.0% (UV) | Sigma-Aldrich
6-Diazo-5-oxo-L-norleucine - Wikipedia
